抗胆固醇负担与年龄和艾滋病史相互作用,在艾滋病毒感染者中放大脆弱性
Maria Mazzitelli1,2,3, Mattia Trunfio4, Davide Leoni1
1Infectious and Tropical Diseases Unit, Padua University Hospital, Padua, Italy.
British journal of clinical pharmacology
|February 22, 2026
概括
抗胆固醇负担 (ACB) 显著导致人类免疫缺陷病毒 (HIV) 感染者的虚弱. 减少ACB可能有助于健康老龄化,并降低这一群体的脆弱性.
科学领域:
- 老年学是一门学科.
- 传染性疾病 传染性疾病
- 临床药理学 临床药理学
背景情况:
- 艾滋病毒感染的老年人经常经历虚弱,多种健康状况和多种药物治疗.
- 抗胆固醇药物经常被处方,造成不良身体和认知结果的风险.
- 抗胆固醇负担对艾滋病毒感染者的脆弱表型的具体影响尚不清楚.
研究的目的:
- 研究艾滋病毒感染者的抗胆固醇负担 (ACB) 和脆弱性之间的关联.
- 为了确定ACB是否是脆弱的独立预测因素.
- 通过人口和临床因素来探索ACB-脆弱性关系的效果修改.
主要方法:
- 在第三级艾滋病毒诊所对1200名艾滋病毒感染者进行了横截面研究.
- 抗胆固醇负担使用抗胆固醇认知负担尺度进行测量.
- 使用修改后的弗里德表型和洛克伍德脆弱指数来评估脆弱性,并使用多变量线性模型进行分析.
主要成果:
- 抗胆固醇负担 (ACB) 是脆弱的强有力的独立相关因子,根据Fried和Rockwood标准测量.
- 随着年龄的增长,获得性免疫缺陷综合征 (艾滋病) 的病史以及艾滋病毒感染的持续时间的延长,ACB和脆弱性之间的联系显著放大.
- 年龄和慢性病也被确定为脆弱的独立相关因子.
结论:
- 抗胆固醇负担是一个重要的,可修改的因素,有助于艾滋病毒感染者的脆弱性.
- 在老年人和有严重免疫抑制史的人群中,ACB对脆弱性的影响不成比例地高.
- 将ACB评估和减记干预措施整合到HIV护理中,可以增强功能衰老并减少脆弱性.
相关概念视频
01:15Drug Dosing: Geriatric Patients
309
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
309
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
257
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
257
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
289
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
289
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
274
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
274
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
750
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
750
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
249
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
249